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1. Introduction 
It is now generally accepted that in all eukaryotes 
the DNA and the histone proteins are complexed 
together in a repeating unit called the nucleosome 
(review [ 11). The nucleosome consists of -200 base- 
pairs of DNA complexed with an octamer of histones 
H2A, H2B, H3 and H4, and interacts with 140-145 
basepairs of DNA to form the core particle of the 
nucleosome. The fifth histone, Hl , is associated with 
a variable length of spacer or linker DNA which sepa- 
rates the repeating units. The amino acid sequences of 
all 5 histones have now been known for a number of 
years. However, until recently very little sequence 
information has been available for any of the non- 
histone chromosomal proteins involved in the nucleo- 
some structure. We have been studying a particular 
group of non-histone chromosomal proteins called the 
HMG proteins (review [2]). The presence of HMG 
proteins in a variety of organisms and tissues, including 
avian erythrocytes [3,4], trout testis and trout liver 
[5,6], wheat and yeast [7] and insects [g] implies a 
widespread occurrence in eukaryotic nuclei. There are 
4 main HMG proteins in thymus, HMG 1,2,14 and 
17. All 4 of these proteins have been isolated in a pure 
form from both pig and calf thymus [9-l I], and have 
all been shown to be present in isolated nucleosomes 
[ 121. The primary structures of both HMG 14 and 17 
have been determined [ 13 ,141. Because of the quan- 
tities of the HMG proteins present in the nucleus 
+ Present address: School of Biological Sciences, Hatfield 
Polytechnic, Hatfield, Herts, England 
* Present Address: MRC Clinicaland Population Cytogenetics 
Unit, Western General Hospital, Crewe Road, Edinburgh, 
Scotland 
264 
(1 OS-lo6 molecules of each protein), we consider that 
the HMG proteins are structural proteins, possibly 
involved in the higher order structure of the chromatin, 
and not involved in specific gene control. There is evi- 
dence, however, that HMG 14 and 17 may be involved 
in the maintenance of the structure of active genes 
[15,16]. 
One of the noteworthy features of HMG proteins 
1 and 2 is that >50% of their amino acid residues are 
charged. Like the histones, 25% of the residues in 
both proteins are basic. However, unlike the histones, 
both proteins also contain 30% acidic amino acids [2]. 
In [ 17,181 we have published sequence data for 
the cyanogen bromide peptides from both HMG 1 and 
2. Here, we describe the production of peptides from 
HMG 1 and 2 by peptic cleavage of the native protein 
and by tryptic cleavage of the succinylated protein. 
Sequence data for these peptides, together with the 
data in [ 17,181, allow the description of the primary 
structures of both HMG 1 and 2. 
2. Experimental 
2.1. Isolation of proteins 
Proteins HMG 1 and 2 were prepared as in [2]. 
2.2. Pepsin cleavage of HMG 1 and 2 
Pepsin (1:2000, w/w) was added to protein (5 
mg/ml in 5% acetic acid) and digestion allowed to 
continue for 1 h at 4°C. At the end of this time the 
reaction was stopped by the addition of pepstatin 
(10 X wt pepsin used, added in a small volume of 
DMSO). The digest mixture was then rotary evapo- 
rated to dryness and dissolved in 20 ml sodium ace- 
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tate buffer (0.01 M (pH 3.8) containing 0.5 ml 
@mercaptoethanol/l). This solution was run onto a 
column of CM 52 cellulose (2.4 X 40 cm) equilibrated 
in the same buffer, at a flow rate of 45 ml/h. Peptides 
were eluted by the passage of a further 50 ml buffer 
followed by a salt gradient (2 X 700 ml, 0.1-0.6 M 
NaCl) in the same buffer. Eluted peptides were 
detected by their Azae. Pooled samples were rotary 
evaporated to a small volume (-5 ml) then desalted 
by passage through a column of Sephadex G-75 
equilibrated in 0.01 N HCI. Eluted peaks were rotary 
evaporated to dryness. 
2.3. Succinylation and tryptic cleavage of HMG 1 
and 2 
Protein was dissolved in water (10 mg/ml) and the 
pH adjusted to 7 .O with solid sodium carbonate. Solid 
succinic anhydride (1 .O g/l 00 mg protein) was added 
in small aliquots and the pH maintained at 7-7.5 by 
the addition of solid sodium carbonate. When all the 
succinic anhydride had been added the pH was raised 
to 8 by the addition of sufficient sodium carbonate 
and the solution left for 2 h. The succinylated protein 
was recovered by dropping the pH of the solution to 
2 with hydrochloric acid. Precipitated protein was col- 
lected by centrifugation, washed once with 0.1 N HCl, 
then 3 times with acetone and dried under vacuum. 
Succinylated protein was dissolved in ammonium 
bicarbonate solution (10 mg/ml, 0.2 M), trypsin 
(1 :lOO, w/w) added, and the sample incubated at 
37’C for 4 h, at which time the digest was stopped by 
the addition of soya bean trypsin inhibitor (equal 
w/w of trypsin used). The sample was rotary evapo- 
rated to dryness and dissolved in 20 ml 0.01 M 
ammonia/O.1 M NaCl, then run onto a column of 
QAE-A50 Sephadex (2.4 X 25 cm) equilibrated in 
the same buffer, at a flow rate of 30 ml/h. Peptides 
were eluted by the passage of 50 ml buffer followed 
by a salt gradient from 0.1-l .O M NaCl(2 X 500 ml) 
in the same buffer. Eluted peptides were identified 
and desalted as described for the pepsin digest with 
the exception that the desalting step was carried out 
in 0.01 M ammonia. 
2.4. Peptide sequence determinations 
Automated Edman degradations of large peptides 
PSO residues) were carried out on a Beckman 890C 
protein sequencer using a 0.1 M quadrol buffer pro- 
gramme with a double cleavage step on each cycle, 
essentially as in [ 191. The same programme was used 
for small peptides (<50 residues) but with the addi- 
tion that polybrene (5 mg) was used as a carrier and 
taken through 3 cycles of the Edman degradation 
together with 100 nmol glycyl glycine prior to each 
sequenator un [ 191. Because of their highly charged 
nature it was not found necessary to use polybrene 
with any of the succinylated peptides. 
PTH derivatives of released amino acids were 
determined both directly by high pressure liquid 
chromatography (HPLC) and indirectly by back-hy- 
drolysis to the free amino acid. HPLC was carried out 
on a DuPont 830 Liquid Chromatogram using a 
Partisil PX5 ODS column (Whatman). PTH amino 
acids were eluted with a linear gradient of acetonitrile 
from 15-48% in 0.01 M sodium acetate buffer (pH 
4.5) over 7 min, then holding at 48% acetonitrile for 
a further 4 min. Eluted PTH amino acids were identi- 
fied by their A2e9. Back-hydrolysis of PTH amino 
acids was carried out in 65% hydriodic acid at 1 10°C 
for 24 h. Liberated amino acids were identified on a 
Rank-Hilger Chromaspek amino acid analyser. 
3. Results 
3.1. The primary structure of HMG I 
The primary structure of HMG 1 is shown in 
fig.1 together with details of the major peptide 
sequences used to derive this sequence. 
Ion-exchange chromatography of the products 
from tryptic cleavage of succinylated HMG 1 gave 5 
major peaks but also a background of a number of 
minor peaks. It was obvious from the results obtained 
from this digest that tryptic cleavage did not occur 
exclusively at arginine residues. However, despite 
this, 3 major succinylated peptides were isolated 
which were of use for sequence studies. Peptide A 
was a 22 residue peptide running from residues 
56-77. The total sequence of this peptide allowed 
the overlap of 2 CNBr peptides (peptides CB5-1 and 
CB5-2, residues 60-70 and 71-82) [ 171 and also 
extended the sequence at the N-terminus of one of 
these peptides (at residues 55-59). Peptide B pro- 
vided the overlap between these 2 linked peptides and 
a further CNBr peptide (peptide CB3) at residues 
8 I-83 (CB3 commences at residue 83) [ 171. Peptide 
C was produced by cleavage at arginine at residue 
169. Sequenator analysis of this peptide allowed 32 
residues to be determined. This peptide starts towards 
the end of the N-terminal sequence of CNBr peptide 
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our final sequence data with the amino acid analysis 
of P2 suggested a region of undetermined sequence 
between residues 39 and 55. VS-protease digestion of 
P2 had given one unplaced peptide; 
Phe-Ser-Lys-Lys-Cys-Ser-Glu 
which has been placed in this region. The same digest 
also gave the peptide: 
Arg-Trp-Lys-Tlr-Met-Ser-Ala-Lys-Glu (resi- 
dues 55-63) 
which suggests residue 54 in Glu. However, despite 
exhaustive studies of tryptic, V8-protease and ther- 
moiytic peptides from P2, peptides necessary to 
account for the 8 residues till remaining to be placed 
in sequence were not found. However, since both 
HMG 1 and 2 have complex isoelectric focusing pat- 
terns, and since the reason for this complexity has 
yet to be determined, it is possible that our inability 
to determine the sequence in this region is due to the 
fact that HMG 1 is microheterogeneous in this region, 
in much the same way at Hl has short microheter- 
ogeneous regions [22,23]. 
Analysis of peptide Pl showed peptic cleavage to 
nave occurred essentially at the Phe-Phe bond at 
residues 109-l 10, but minor cleavages also occurred 
at the Phe-Leu and Leu-Phe bonds between residues 
1 IO- 112. Sequenator analysis of 35 residues of this 
peptide allowed the overlap of 2 major CNBr pep- 
tides CB3 and CB2 [ 171. Amino acid analysis howed 
peptide Pl to extend to the C-terminus of the mole- 
cule. Tryptic and V8-protease digestion of peptide 
Pl provided peptides which covered the majority of 
the sequence from residues 110 up to and including 
the HGA sequence which starts at residue 192. Only 
one unplaced peptide, a tryptic peptide with the 
partial sequence Asp-Ile-Ala-Tyr was isolated from 
Pl and this has been placed after the HGA peptide. 
The C-terminal of the molecule had been determined 
as -Phe-Ala-Lys in [24]. Comparison of our 
sequence data with the amino acid analysis of Pl 
therefore suggests a further 18 residues remain to be 
placed in sequence after the HGA peptide. Again, the 
possibility that microheterogeneity exists in this 
IC 20 
~HMG Ir Gly-Lys-Gly-Asp-Pro Lys Lys-Pro-Arg-G~y-Lys-Met-Ser-Ser-Tyr-Ala-Phe-P~e-Val-Gln-Thr-Ser-Arg-Glu-Glu-Hi~- 
HMG 21 t sly-tys-~ly-ASP-PRO Asn Lys-Pro-Arg-Gly-Lys-Met-Ser-Ser-Tyr-Ala-Phe-Phe-Val-Gln-Thr-Ser-Arg-tlu-Glu-~li~- 
39 
HMG 1, Lys-Lys-Lys-~lsO-~ro-As~-Ala-Ser-Val-Asn-~~~-S==-G~“-(~~~-S~=-~y~-Ly~-~y~-S~~-G~*, Ser,Gly,Ala,Tyr. 
NMG 21 Lys-Lys-Lys-His-Pro-Asp-Ala-Ser-Va~~ASX-Phe-Ser-Glu-(Phe,Ser,Lys~Lys,Cys, Glu, Val,Gly,Ala,Tyr, 
GO 70 
HMG 11 Lys2, Glu2)-Arg-'Crp-Lys-Thr-Met-Ser-Ala-Lys-Glu-LyS Lys-Phe-Glu-Asp-Net-Ala-Lys Asp-Lys-Ala-Aro- 
HMG 21 Lys , )-Arg-Trp-Lys-Thr-Met-Ser-Ala-Lys-Glu-Lys Lys-Phe-Glu-Asp-Met-Ala-Lys 
100 
Lys-Asp-Pro-Asn-Ala-Pro-Lys- 
Lys-Asp-Pro-Asn-Ala-Pro-Lys- 
Glu-His-Pro-Gly-Leu-ser-Ile- 
Arg-Pro-Lys-Ile-Lys Glu-His-Pro-Gly-Leu-ser-Ile. 
Asp-Lys-Gin-~~~-Tyr-Glu Lys-Ala- 
ASP-Lys-Gin-Pro-Tyr-Glu Lys-Ala- 
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HMZ 1, fAs~-~le-Ala-Ala-Tyr,Thr.Pro,hla.Leu.Phe,Arg,Ser~,Glu3,Gly2,Lys~)~~he-Ala-Lys. 
HMG 21 tASp,Ile,Ala,Ala,Tyr.Thr.Pro, LW.l, Arg,Ser2,Gluq,Gly3,Lys5)-Phe-Ala-Lys. 
Fig.2. The primary structure of calf thymus HMG 1 and HMG 2. 
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region should be considered. A smaller peak, PO, 
which eluted just before peptide Pl, was shown to 
be the N-terminal residues l-l 7. Amino acid analysis 
of peptide Pl showed that the second cystein residue 
known to be in the molecule was present in this pep- 
tide. Since it was also known that peptide CB2 con- 
tains a cysteine residue this places the second cysteine 
residue between residue 140 and the C-terminus of 
the molecule. Unfortunately, no cysteine containing 
peptides were recovered from digests of peptide Pl . 
However, since at 2 attempts at sequenator analysis of 
peptide CB2 no residue was identified at position 165 
(whereas adjacent residues were easily detected) and 
knowing that PTH derivatives of cysteine are extremely 
difficult to detect, it is possible that residue 165 is cys- 
teine. However, we appreciate that this point is not 
proven. As well as these sequence data, an elastase 
digest of total HMG 1 (unpublished) provided peptides 
ranging in size from 2-18 residues. These peptides 
were all sequences manually using the dansyl-Edman 
method and all have been placed in the sequence 
shown in fig.1. The elastase peptides accounted for a 
total of 180 amino acid residues and the cleavage posi- 
tions for these peptides were all in agreement with the 
known specificity for elastase. 
regions of sequence remain indeterminate, the overall 
architecture of both molecules is immediately appar- 
ent. Considering the highly homologous nature of 
these 2 proteins, it seems likely that the small differ- 
ence in the total number of residues determined for 
both proteins (259 in HMG 1,256 in HMG 2) is prob- 
ably a consequence of the methods used to determine 
the compositions of the undetermined regions (sub- 
tracting a known sequence from an amino acid com- 
position) and not an indication of different lengths 
of the 2 proteins. It has been known since the original 
characterisation studies on HMG 1 and 2 that the two 
proteins have very similar structures [24], and this is 
borne out by the sequence data. A comparison of the 
primary structures of HMG 1 and 2 is shown in Bg.2. 
Of the 188 residues shown in sequence in fig.2, only 
37 differences occur between the 2 proteins, and 19 
of these changes can be considered as conservative. 
HMG 1 and 2 are therefore highly homologous pro- 
teins. Comparison with sequence data for other chro- 
mosomal proteins shows that no extensive regions of 
sequence homology exist between HMG 1 and 2 and 
the histones, or any of the other HMG proteins. 
3.2. The primary structure of HMG 2 
In both the peptic digest and tryptic digest of suc- 
cinylated protein, peptides were obtained for HMG 2 
which were analogous to those obtained for HMG 1. 
This is not surprising considering the strong sequence 
homology between HMG 1 and 2 (see below). For the 
peptic peptides PI and P2 the approach was the same 
as used for HMG 1, namely, further digestion with 
trypsin, thermolysis and VS-protease, followed by 
peptide purification. Again, peptides were obtained 
which almost totally accounted for the sequence data 
that was obtained by sequenator analysis, but again 
the same 2 regions of indeterminate sequence remain- 
ed. The only difference between the total data 
obtained for HMG 1 and 2 was that the cysteine con- 
taining peptide which was isolated from peptide Pl 
and HMG 1 was not isolated from the corresponding 
Pl peptide from HMG 2. 
One of the interesting features of HMG 1 and 2 is 
the fact that >50% of their amino acids are charged, 
and the sequence data have revealed an asymmetric 
distribution of these charged groups. The most intri- 
guing observation in both proteins is the presence of a 
continuous sequence of 35-40 aspartic and glutamic 
acid residues in the C-terminus of the molecule (resi- 
dues 191-232 in HMG 1). This region is referred to 
as tne riGA region (High Glutamic and Aspartic), and 
is preceded in both proteins by a group of basic 
amino acids. The HGA region in both proteins HMG 
1 and HMG 2 must obviously play an important role 
in the function of these proteins, but the exact func- 
tion of the HGA region has yet to be determined. In 
contrast to this highly acidic region, the basic amino 
acids are fairly evenly distributed, although small 
clusters of basic amino acids do occur in both pro- 
teins, e.g., the sequences: 
Arg-Glu-Glu-His-Lys-Lys-Lys-His (residues 
23-30 in HMG 1 and 2); 
Lys-Lys-Gly-Lys-Lys-Lys (residues 92-97 in 
HMG 2); and 
Lys-Ser-Lys-Lys-Lys-Lys (residues 186-l 92 in 
4. Discussion HMG 1). 
Comparison of the sequence data for HMG 1 and 2 
is shown in fig.2. Although for both proteins 2 short 
However, no extended regions of basic residues, 
similar to the highly grouped acidic residues of the 
HGA peptide, exist in the molecule. Clusters of hy- 
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drophobic amino acids such as Ala-Phe-Phe-Leu- 
Phe-Ala (residues 108-I 13) and Tyr-Ala-Phe- 
Phe-Val-Gln (residues 15-20) also occur in the 
N-terminal half of both molecules. Such hydrophobic 
regions may well represent sites of protein-protein 
interactions much in the same way as the hydrophobic 
regions of the histones are thought to bind together 
in the histone octamer core of the nucleosome. The 
overall picture of the HMG 1 and 2 molecule is, there- 
fore, one of a basic N-terminal half containing clus- 
ters of basic and hydrophobic amino acids but few 
acidic amino acids, whereas the C-terminal region 
contains the majority of the acidic residues in a con- 
tinuous sequence. Side chain modi~cation by acetyla- 
tion, methyIation and ADP-ribosylation has been 
reported for HMG 1, and sites of acetylation (at lysine 
residues 2 and 11) have been positively identified 
[25]. This reversible modification of lysine by acetyl- 
ation in the N-terminal region is comparable with 
that observed with the histones. 
In the light of the above sequence data it is difficult 
to imagine HMG 1 and 2 as having different func- 
tions. A reasonable explanation for the sequence 
similarity between HMG I and 2 would be that they 
have evolved from a common ancestral gene. Gene 
duplication followed by the separate evolution of 
both genes would give rise to two proteins with 
closely related sequences. Multiple forms of a chro- 
mosomal protein produced by microheterogeneity in 
the amino acid sequence has, of course, already been 
demonstrated in the case of histone Hl [22,23], 
although in this case as well the reasons for the heter- 
ogeneity are not known. Unfortunately, the absence 
of a function for the HMG proteins other than 
‘structural’ precludes the comparison of these 2 pro- 
teins in some form of biological assay. Until such 
time as this can be done, the reason for the presence 
in chromatin of 2 such closely-reIated proteins will 
remain a mystery. However, if HMG 1 and 2 do have 
different functions, then the nature of this difference 
is most likely to relate to the structure preceding the 
HGA sequence (residues 1744190). This region shows 
the greatest density of differences between the two 
proteins (9 changes in 13 residues), and in particular 
involves 3 proline residues. Additionally, there is an 
extra proline residue at the beginning of the HGA 
sequence in HMG 2 and one further proline residue 
within the HGA sequence. These differences will 
produce considerable conformational changes between 
the 2 proteins in this region, and will almost certainly 
involve the HGA peptide in both proteins being held 
in different configurations with respect to the rest of 
the molecule. It is interesting to note that the 11 
remaining prohne residues found in the remainder of 
the molecule are all in identical positions in HMG 1 
and 2, i.e., no gross conformational changes have 
been brought about in the rest of the molecule by the 
addition or deletion of proline residues. Otherwise 
the majority of all other differences occur as single 
changes and are fairly regularly distributed through- 
out the protein. 
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